Close Menu

NEW YORK (GenomeWeb) – Biocept said today that it has entered into a clinical collaboration with Sarah Cannon Research Institute in the area of breast cancer screening.

Specifically, the goal of the collaboration is to determine the clinical utility of using Biocept's OncoCEE technology to detect biomarkers in circulating tumor cell and circulating tumor DNA in blood samples from estrogen-positive breast cancer patients. The partners will also assess whether such biomarkers can help assess the response of tumors to treatment over time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sep
18
Sponsored by
Bionano Genomics

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Oct
03
Sponsored by
Agilent

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10
Sponsored by
Roche

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
21
Sponsored by
Agilent

Genomics is a key element in the potential of precision medicine to transform oncology.